Thomas is a dynamic life-science entrepreneur who established Santhera Pharmaceuticals (SIX Exchange: SANN) as successful Biotech/Specialty Pharma company in the Basel area (Switzerland). In the past 20 years he held executive manager positions (CSO and CEO) at Santhera and successfully executed merger/acquisitions, product licensing and turn-around situations.

In 2020 Thomas became Managing Partner at Viopas Venture Consulting. Currently Thomas holds Board positions at several private and public pharma/biotech companies.

Thomas has a PhD in Biology and is lecturer in neurosciences at the Biozentrum, University of Basel. He is an internationally recognized scientist with track record in clinical research of orphan diseases.